Junko Mukohyama

6PUBLICATIONS
34CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Surgery
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 29, 2026
Multiplex Immunofluorescence-defined CXCL13-associated TLS-like Niches Predict Outcome in Bladder Cancer.

|Sep 17, 2026
Can Chemoradiotherapy Expand Immune Checkpoint Blockade Responsiveness in Mismatch Repair-Proficient Rectal Cancer?

|Jul 24, 2026
Translational Gap in Biomarker Discovery: Tumor Surface Markers Rarely Mirror Circulating Levels.

|Jun 15, 2026
Timing and motivation behind the decision to become a surgeon: Gender and optimal recruitment insights.

|Feb 03, 2025
The E2F4 transcriptional repressor is a key mechanistic regulator of colon cancer resistance to irinotecan (CPT-11).

Junichi Matsubara, Yong Fuga Li, Sanjay Koul

Pageof 1

Frequent Collaborators

1 joint publications

Junichi Matsubara

1 joint publications

Yong Fuga Li

1 joint publications

Sanjay Koul

1 joint publications

Luis E Valencia Salazar